TECHNOLOGY

The human body has a powerful immune system, and one of its white blood cells called a T-cell is like a solider capable of attacking and killing abnormal cancerous cells. However, in cancer patients, these T cells are compromised, either fail to target or recognize cancerous cells, or are too few in number to lead an strong attack. Aurora’s revolutionary CAR T Cell Therapy change a cancer patient’s own weak T cells into “bionic” killing machines —a highly targeted army that can kill cancer. A cancer patient’s T cells are removed from a blood draw, genetically engineered in a laboratory, expanded to almost a billion CAR T cells, and re-infused back into the patient where they are better able to kill cancer.

Courtesy of Nature Magazine

Platform

Learn More

Preclinical

Learn More

Sarcoma

Learn More

Glioblastoma

Learn More